AstraZeneca is global innovation-driven biopharmaceutical company specialising in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.
AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. They also focus on getting the best from every medicine they make by exploring all the ways it can be used or improved.
Their business strategy sets out their path to success in delivering great medicines to patients through innovative science and global excellence in development and commercialisation.
|Apr 16, 2016||Takeda Respiratory Business||$575M in Cash|
|Dec 17, 2015||Acerta Pharma||$5.7B (terms undisclosed)|
|Nov 6, 2015||ZS Pharma||$2.7B in Cash|
|Jul 30, 2014||Almirall||Unknown|
|Oct 15, 2013||Spirogen||$440M (terms undisclosed)|
|Jun 10, 2013||Pearl Therapeutics||$1.15B (terms undisclosed)|
|May 29, 2013||Omthera Pharmaceuticals||$443M (terms undisclosed)|
|Dec 23, 2009||Novexel||$505M in Cash|
|Feb 1, 2007||Arrow Therapeutics||$150M in Cash|
Current Team (16)Update
15 Stanhope Gate
London, W1K 1LN